What is RMGP Biopharma Investment Fund's primary investment focus?

RMGP Biopharma Investment Fund focuses on innovative early-stage biotherapeutics, primarily investing in companies operating in Israel's FutuRx incubator.

When was RMGP Biopharma Investment Fund founded?

RMGP Biopharma Investment Fund was founded in 2017.

What are the typical investment stages for RMGP Biopharma Investment Fund?

RMGP Biopharma Investment Fund typically invests in Seed and A Round stages.

Can you name some of RMGP Biopharma Investment Fund's portfolio companies?

RMGP Biopharma Investment Fund's portfolio includes companies such as BiomX, which develops microbiome therapies, and ImmPACT Bio, focused on CAR-T cell therapies.

Has RMGP Biopharma Investment Fund had any notable exits?

Yes, ImmPACT Bio, a portfolio company of RMGP Biopharma Investment Fund, was acquired by Lyell Immunopharma in October 2024. Additionally, BiomX underwent a Reverse Merger Event in November 2019 and is listed on the NYSE.

What is the sector concentration of RMGP Biopharma Investment Fund's portfolio?

RMGP Biopharma Investment Fund's portfolio is entirely concentrated in the Health Tech & Life Sciences sector, with 16 portfolio companies in this area.

Which individuals are General Partners at RMGP Biopharma Investment Fund?

Yaron Breski and Assaf Keret are General Partners at RMGP Biopharma Investment Fund.

What is the most recent investment activity by RMGP Biopharma Investment Fund?

RMGP Biopharma Investment Fund made investments in September 2022.

RMGP Biopharma Investment Fund

An early-stage venture capital fund focused on Israeli biopharma startups.

Venture Capital Active New York, United States Est. 2017

Visit website ↗

Last updated 2026-07-20

Raised $34M Undisclosed Round, Apr 2019
Raised $30M Undisclosed Round, May 2017

Portfolio

in our dataset

Rounds participated

Rounds led

Rounds' value

$45.7M

total disclosed, rounds participated

Stages

Seed, A Round

About

The RMGP Biopharma Investment Fund is an early-stage venture capital fund managed by RM Global Partners and RMGLOBAL Healthcare Fund Management. It invests in Israel-based companies, particularly those within the FutuRx biotech accelerator, focusing on life sciences, oncology, pharmaceutical, and biotechnology sectors.

Portfolio · 9

Symbol Therapeutics

Modified Protein for Treatment of Autoimmune Diseases

1 round $3.0M committed Latest: 2022-09

Circuit-Bio

Platform of Logical Gene Circuits for Cancer Immunotherapy

1 round Latest: 2020-09

JAMM Therapeutics

Systemic Lupus Erythematosus Treatment

1 round Latest: 2020-05

Nevrox

Therapeutic Small Molecule Inhibitor for Treating Neurodegenerative Disorders

1 round Latest: 2019-11

MabTrix

Therapeutic Monoclonal Antibody for Bowel Disease

1 round Latest: 2019-06

Pi Therapeutics

Inhibitors for Cancer Treatment

1 round $19.7M committed Latest: 2019-05

Moya Bio

Tumor Immune Conditioning Agents

1 round $3.0M committed Latest: 2019-01

Ramino-Bio

Oral drug for treating cardio-metabolic disease and rare MSUD

1 round Latest: 2018-09

Mitoconix Bio

Therapeutics for Neurodegenerative Diseases

1 round $20.0M committed Latest: 2017-06

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences16

Funds · 1

1 — $64M Apr 2019

Q&A

What is RMGP Biopharma Investment Fund's primary investment focus?: RMGP Biopharma Investment Fund focuses on innovative early-stage biotherapeutics, primarily investing in companies operating in Israel's FutuRx incubator.
When was RMGP Biopharma Investment Fund founded?: RMGP Biopharma Investment Fund was founded in 2017.
What are the typical investment stages for RMGP Biopharma Investment Fund?: RMGP Biopharma Investment Fund typically invests in Seed and A Round stages.
Can you name some of RMGP Biopharma Investment Fund's portfolio companies?: RMGP Biopharma Investment Fund's portfolio includes companies such as BiomX, which develops microbiome therapies, and ImmPACT Bio, focused on CAR-T cell therapies.
Has RMGP Biopharma Investment Fund had any notable exits?: Yes, ImmPACT Bio, a portfolio company of RMGP Biopharma Investment Fund, was acquired by Lyell Immunopharma in October 2024. Additionally, BiomX underwent a Reverse Merger Event in November 2019 and is listed on the NYSE.
What is the sector concentration of RMGP Biopharma Investment Fund's portfolio?: RMGP Biopharma Investment Fund's portfolio is entirely concentrated in the Health Tech & Life Sciences sector, with 16 portfolio companies in this area.
Which individuals are General Partners at RMGP Biopharma Investment Fund?: Yaron Breski and Assaf Keret are General Partners at RMGP Biopharma Investment Fund.
What is the most recent investment activity by RMGP Biopharma Investment Fund?: RMGP Biopharma Investment Fund made investments in September 2022.

Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Website	rmgpfund.com/

Identifiers & details

Founded	2017

Radar intelligence

Web history (Wayback)

Domain	rmgpfund.com